EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Primary Hyperparathyroidism Associated With the Glial Cell Missing 2 Y394S Variant: Case Report

Asif Surani, Beth Lalande, Michael Muriello, Joseph L. Shaker

AACE Endocrinology and Diabetes · 2026-09 · 13 (5) · 824-826

DOI: 10.1016/j.aed.2026.06.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Asif Surani und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary hyperparathyroidism (PHPT) is predominantly sporadic, although germline variants contribute to both syndromic and non-syndromic familial forms. Gain-of-function variants in glial cell missing 2 ( GCM2) have recently been implicated in familial and sporadic PHPT. The GCM2 p.Tyr394Ser variant occurs with increased frequency in individuals of Ashkenazi Jewish ancestry; however, its penetrance and clinical significance remain uncertain, and it is currently classified as a variant of uncertain significance in ClinVar. Case report We describe a case of a 64-year-old woman of Ashkenazi Jewish heritage with PHPT who was found to carry a heterozygous GCM2 c.1181A>C (p.Tyr394Ser) variant. She presented with acquired hypercalcemia, nephrolithiasis, and normal urinary calcium excretion and underwent subtotal parathyroidectomy, which revealed multigland disease.

Discussion

Reported GCM2 variants have been associated with higher rates of multiglandular disease, a greater likelihood of persistent or recurrent hyperparathyroidism after surgery, and, in some cases, parathyroid carcinoma, with familial cases demonstrating greater severity than sporadic cases.

Conclusion

This case highlights the phenotypic variability and diagnostic challenges associated with the GCM2 p.Tyr394Ser variant and underscores the need for further studies to clarify its penetrance and clinical significance in non-familial cases and broader populations.

Zitieren

APA

Surani, A., Lalande, B., Muriello, M., & Shaker, J. L. (2026). Primary Hyperparathyroidism Associated With the Glial Cell Missing 2 Y394S Variant: Case Report. AACE Endocrinology and Diabetes, 13(5), 824-826. https://doi.org/10.1016/j.aed.2026.06.008

Vancouver

Surani A, Lalande B, Muriello M, Shaker JL. Primary Hyperparathyroidism Associated With the Glial Cell Missing 2 Y394S Variant: Case Report. AACE Endocrinology and Diabetes. 2026;13(5):824-826. doi:10.1016/j.aed.2026.06.008

BibTeX
@article{Surani2026,
  author = {Surani, Asif and Lalande, Beth and Muriello, Michael and Shaker, Joseph L.},
  title = {Primary Hyperparathyroidism Associated With the Glial Cell Missing 2 Y394S Variant: Case Report},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  volume = {13},
  number = {5},
  pages = {824--826},
  doi = {10.1016/j.aed.2026.06.008}
}
Kostenlos starten →